NextCure Inc. (NXTC)
NextCure Statistics
Share Statistics
NextCure has 28.01M shares outstanding. The number of shares has increased by 0.12% in one year.
| Shares Outstanding | 28.01M |
| Shares Change (YoY) | 0.12% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 57.32% |
| Shares Floating | 21.84M |
| Failed to Deliver (FTD) Shares | 1.31K |
| FTD / Avg. Volume | 1.46% |
Short Selling Information
The latest short interest is 73.77K, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 73.77K |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 1.89 |
Valuation Ratios
The PE ratio is -0.39 and the forward PE ratio is -0.53. NextCure's PEG ratio is 0.03.
| PE Ratio | -0.39 |
| Forward PE | -0.53 |
| PS Ratio | 0 |
| Forward PS | 0.5 |
| PB Ratio | 0.33 |
| P/FCF Ratio | -0.52 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NextCure.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.5, with a Debt / Equity ratio of 0.08.
| Current Ratio | 7.5 |
| Quick Ratio | 7.5 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.09 |
| Debt / FCF | -0.12 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.29M |
| Employee Count | 43 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -83.33% in the last 52 weeks. The beta is 0.71, so NextCure's price volatility has been higher than the market average.
| Beta | 0.71 |
| 52-Week Price Change | -83.33% |
| 50-Day Moving Average | 0.7 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 22.22 |
| Average Volume (20 Days) | 89.84K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -59.75M |
| Net Income | -55.65M |
| EBITDA | -54.34M |
| EBIT | -57.21M |
| Earnings Per Share (EPS) | -1.99 |
Balance Sheet
The company has 27.73M in cash and 5.15M in debt, giving a net cash position of 22.57M.
| Cash & Cash Equivalents | 27.73M |
| Total Debt | 5.15M |
| Net Cash | 22.57M |
| Retained Earnings | -380.14M |
| Total Assets | 80.86M |
| Working Capital | 62.23M |
Cash Flow
In the last 12 months, operating cash flow was -40.8M and capital expenditures -474K, giving a free cash flow of -41.28M.
| Operating Cash Flow | -40.8M |
| Capital Expenditures | -474K |
| Free Cash Flow | -41.28M |
| FCF Per Share | -1.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NXTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NXTC is $3.5, which is 775% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.5 |
| Price Target Difference | 775% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -7.48 |
| Piotroski F-Score | 2 |